Conversely, Ang1 blocking failed to provide tumour growth inhibition, but it prevented tumour vessel normalization including improved EC–EC contacts and EC–pericyte interactions, induced by Ang2 blocking peptibodies, suggesting that Ang1 contributes to vessel stabilization during anti-angiogenic therapy [95,99,104]. The gene discussed is ANGPT1; the disease is neoplasm.